🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pilot study of combination low dose rate brachytherapy (LDR) adde...
Status
Active Not Recruiting
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2021-05-27
Trial ID
NCT04620603
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This is a phase I, open label, plus expansion clinical trial evaluating the...
Status
Recruiting
Location
Children's Health Orange County (CHOC)
Start Date
2022-01-10
Trial ID
NCT04943848
Treatments Being Tested
This open labelled first in human dose phase 1/2a study is designed to eval...
Status
Completed
Location
Charité Research Organisation, Campus Benjamin Franklin
Start Date
2018-04-04
Trial ID
NCT03548467
Treatments Being Tested
This is a single-arm, non-randomized pilot study to evaluate the efficacy a...
Status
Completed
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2021-02-25
Trial ID
NCT04454489
Treatments Being Tested
This study will evaluate the safety and effectiveness of a combination of s...
Status
Recruiting
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2023-07-01
Trial ID
NCT05915442
Treatments Being Tested
This study is being done to answer the following question: Can the chance o...
Status
Recruiting
Location
BCCA - Abbotsford
Start Date
2025-04-07
Trial ID
NCT06623461
Treatments Being Tested
This is a multicenter, prospective, phase II study evaluating total neoadju...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-20
Trial ID
NCT07175636
Treatments Being Tested
This study will examine the impact of anti-programmed cell death 1 (PD1) th...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-02-20
Trial ID
NCT06599619
Treatments Being Tested